(Q35977364)

11 August 2017

Phase I and pharmacologic study of irinotecan in combination with cisplatin for advanced lung cancer (English)

1 reference

11 August 2017

1 reference

1 reference

1 reference

N Masuda

1

1 reference

11 August 2017

M Fukuoka

2

1 reference

11 August 2017

S Kudoh

3

1 reference

11 August 2017

Y Kusunoki

4

1 reference

11 August 2017

K Matsui

5

1 reference

11 August 2017

N Takifuji

6

1 reference

11 August 2017

K Nakagawa

7

1 reference

11 August 2017

M Tamanoi

8

1 reference

11 August 2017

T Nitta

9

1 reference

11 August 2017

T Hirashima

10

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 October 1993

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

68

1 reference

11 August 2017

777-782

1 reference

11 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1993.427

11 August 2017

0 references

cites work

A new international staging system for lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968602

Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968602

An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968602

CPT-11 Converting Enzyme from Rat Serum: Purification and Some Properties

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968602

Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothec in, a novel water-soluble derivative of camptothecin, against murine tumors

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968602

Inhibition of spontaneous and experimental metastasis by a new derivative of camptothecin, CPT-11, in mice

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968602

Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I

24 September 2018

1 reference

12 December 2020

On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex

1 reference

12 December 2020

Metabolism and pharmacokinetics of the camptothecin analogue CPT-11 in the mouse

1 reference

12 December 2020

Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung Cancer

1 reference

12 December 2020

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer

1 reference

12 December 2020

CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer

1 reference

12 December 2020

CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1993.427

1 reference

11 August 2017

1 reference

11 August 2017

1 reference